Diabetes and cancer: Looking at the multiligand/RAGE axis

doi:10.4239/wjd.v2.i7.108

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4796)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

427

HTML

3962

Figures (1-2)

407

Sum=4796

Jul 15, 2011 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (43)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Basic Research

World J Diabetes. Jul 15, 2011; 2(7): 108-113
Published online Jul 15, 2011. doi: 10.4239/wjd.v2.i7.108

Full Size Figure Download Figure

Figure 1 RAGE engagement activates many signaling pathways which are involved in both diabetes-associated vascular complications and tissue damage, and as well as in the tumor microenvironment-associated inflammatory milieu. RAGE: Receptor of advanced glycation end-products.

Citation: Rojas A, González I, Morales E, Pérez-Castro R, Romero J, Figueroa H. Diabetes and cancer: Looking at the multiligand/RAGE axis. World J Diabetes 2011; 2(7): 108-113
URL: https://www.wjgnet.com/1948-9358/full/v2/i7/108.htm
DOI: https://dx.doi.org/10.4239/wjd.v2.i7.108